Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.92 USD | +0.34% | +13.62% | +8.96% |
May. 13 | UBS Adjusts Aveanna Healthcare Price Target to $1.70 From $1.60, Maintains Sell Rating | MT |
May. 09 | Transcript : Aveanna Healthcare Holdings Inc., Q1 2024 Earnings Call, May 09, 2024 |
Evolution of the average Target Price on Aveanna Healthcare Holdings Inc.
Price target over the last 5 years
History of analyst recommendation changes
Analysts' Consensus
Consensus detail
Consensus revision (last 18 months)
Analysts covering Aveanna Healthcare Holdings Inc.
UBS | |
Deutsche Bank Securities | |
JPMorgan Chase | |
RBC Capital Markets | |
Truist Securities | |
Raymond James | |
Credit Suisse | |
Stephens Inc. | |
Barclays | |
Jefferies & Co. | |
BofA Securities | |
BMO Capital | |
J.P. Morgan Chase |
EPS Revisions
- Stock Market
- Equities
- AVAH Stock
- Consensus Aveanna Healthcare Holdings Inc.